286 related articles for article (PubMed ID: 32562436)
1. Outcomes of 43 small breed dogs treated for splenic hemangiosarcoma.
Story AL; Wavreille V; Abrams B; Egan A; Cray M; Selmic LE
Vet Surg; 2020 Aug; 49(6):1154-1163. PubMed ID: 32562436
[TBL] [Abstract][Full Text] [Related]
2. Epirubicin in the adjuvant treatment of splenic hemangiosarcoma in dogs: 59 cases (1997-2004).
Kim SE; Liptak JM; Gall TT; Monteith GJ; Woods JP
J Am Vet Med Assoc; 2007 Nov; 231(10):1550-7. PubMed ID: 18021000
[TBL] [Abstract][Full Text] [Related]
3. Laparoscopic splenectomy for treatment of splenic hemangiosarcoma in a dog.
Collard F; Nadeau ME; Carmel EN
Vet Surg; 2010 Oct; 39(7):870-2. PubMed ID: 20723196
[TBL] [Abstract][Full Text] [Related]
4. Splenomegaly in dogs. Predictors of neoplasia and survival after splenectomy.
Johnson KA; Powers BE; Withrow SJ; Sheetz MJ; Curtis CR; Wrigley RH
J Vet Intern Med; 1989; 3(3):160-6. PubMed ID: 2778749
[TBL] [Abstract][Full Text] [Related]
5. Prognosis for dogs with stage I or II splenic hemangiosarcoma treated by splenectomy alone: 32 cases (1991-1993).
Wood CA; Moore AS; Gliatto JM; Ablin LA; Berg RJ; Rand WM
J Am Anim Hosp Assoc; 1998; 34(5):417-21. PubMed ID: 9728473
[TBL] [Abstract][Full Text] [Related]
6. Splenic mass diagnosis in dogs undergoing splenectomy according to breed size.
O'Byrne K; Hosgood G
Vet Rec; 2019 May; 184(20):620. PubMed ID: 31040215
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant anthracycline-based vs metronomic chemotherapy vs no medical treatment for dogs with metastatic splenic hemangiosarcoma: A multi-institutional retrospective study of the Italian Society of Veterinary Oncology.
Marconato L; Chalfon C; Finotello R; Polton G; Vasconi ME; Annoni M; Stefanello D; Mesto P; Capitani O; Agnoli C; Amati M; Sabattini S
Vet Comp Oncol; 2019 Dec; 17(4):537-544. PubMed ID: 31251441
[TBL] [Abstract][Full Text] [Related]
8. Timely adjuvant chemotherapy improves outcome in dogs with non-metastatic splenic hemangiosarcoma undergoing splenectomy.
Faroni E; Sabattini S; Guerra D; Iannuzzi C; Chalfon C; Agnoli C; Stefanello D; Polton G; Ramos S; Aralla M; Ciaccini R; Foglia A; Okonji S; Marconato L
Vet Comp Oncol; 2023 Mar; 21(1):123-130. PubMed ID: 36633399
[TBL] [Abstract][Full Text] [Related]
9. Surgery and doxorubicin in dogs with hemangiosarcoma.
Ogilvie GK; Powers BE; Mallinckrodt CH; Withrow SJ
J Vet Intern Med; 1996; 10(6):379-84. PubMed ID: 8947871
[TBL] [Abstract][Full Text] [Related]
10. Survival time of dogs with splenic hemangiosarcoma treated by splenectomy with or without adjuvant chemotherapy: 208 cases (2001-2012).
Wendelburg KM; Price LL; Burgess KE; Lyons JA; Lew FH; Berg J
J Am Vet Med Assoc; 2015 Aug; 247(4):393-403. PubMed ID: 26225611
[TBL] [Abstract][Full Text] [Related]
11. Long-term postoperative effects of administration of allogeneic blood products in 104 dogs with hemangiosarcoma.
Ciepluch BJ; Wilson-Robles HM; Pashmakova MB; Budke CM; Ellison GW; Thieman Mankin KM
Vet Surg; 2018 Nov; 47(8):1039-1045. PubMed ID: 30242852
[TBL] [Abstract][Full Text] [Related]
12. Prospective observational study of dogs with splenic mass rupture suggests potentially lower risk of malignancy and more favourable perioperative outcomes.
Stewart SD; Ehrhart EJ; Davies R; Khanna C
Vet Comp Oncol; 2020 Dec; 18(4):811-817. PubMed ID: 32458544
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of hemangiosarcoma in anemic dogs with a splenic mass and hemoperitoneum requiring a transfusion: 71 cases (2003-2005).
Hammond TN; Pesillo-Crosby SA
J Am Vet Med Assoc; 2008 Feb; 232(4):553-8. PubMed ID: 18279091
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of clinical and histologic factors associated with survival time in dogs with stage II splenic hemangiosarcoma treated by splenectomy and adjuvant chemotherapy: 30 cases (2011-2014).
Moore AS; Rassnick KM; Frimberger AE
J Am Vet Med Assoc; 2017 Sep; 251(5):559-565. PubMed ID: 28828962
[TBL] [Abstract][Full Text] [Related]
15. Refining the "double two-thirds" rule: Genotype-based breed grouping and clinical presentation help predict the diagnosis of canine splenic mass lesions in 288 dogs.
Davies O; Taylor AJ
Vet Comp Oncol; 2020 Dec; 18(4):548-558. PubMed ID: 32043696
[TBL] [Abstract][Full Text] [Related]
16. Incidence of malignancy and outcomes for dogs undergoing splenectomy for incidentally detected nonruptured splenic nodules or masses: 105 cases (2009-2013).
Cleveland MJ; Casale S
J Am Vet Med Assoc; 2016 Jun; 248(11):1267-73. PubMed ID: 27172343
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of sternal lymphadenopathy on malignancy and survival in dogs undergoing splenectomy.
Kelsey J; Balfour R; Szabo D; Kass PH
Vet Comp Oncol; 2022 Mar; 20(1):1-7. PubMed ID: 33876555
[TBL] [Abstract][Full Text] [Related]
18. Retrospective evaluation of thrombocytopenia and tumor stage as prognostic indicators in dogs with splenic hemangiosarcoma.
Masyr AR; Rendahl AK; Winter AL; Borgatti A; Modiano JF
J Am Vet Med Assoc; 2021 Mar; 258(6):630-637. PubMed ID: 33683962
[TBL] [Abstract][Full Text] [Related]
19. Premature death in dogs with nontraumatic hemoabdomen and splenectomy with benign histopathologic findings.
Millar SL; Curley TL; Monnet EL; Zersen KM
J Am Vet Med Assoc; 2021 Dec; 260(S1):S9-S14. PubMed ID: 34914629
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of malignancy and factors affecting outcome of cats undergoing splenectomy.
Rossanese M; Williams H; Puerta B; Scott P; Chanoit G; Guillén A
J Am Vet Med Assoc; 2023 Nov; 261(11):1646-1652. PubMed ID: 37582488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
